头颈癌放疗后基因通路改变
研究比较157例头颈癌患者中96例未放疗与61例放疗后复发者的基因表达和通路活性差异。放疗后血管生成、蛋白翻译机器、细胞周期调控和生长因子相关基因上调,Myc活性和缺氧反应相关基因下调;Wnt/β-catenin通路42个基因中19个下调,MYC靶通路199个基因中119个下调。这些通路可能成为预防放疗耐药的潜在靶点。
要点
- 放疗后复发头颈癌血管生成、蛋白翻译、细胞周期和生长因子基因上调
- 放疗后Myc活性和缺氧反应相关基因下调
- Wnt/β-catenin和MYC靶通路改变或为放疗耐药潜在靶点
核心结论
- 放疗后手术挽救复发的头颈癌患者基因表达及Wnt/β-catenin和MYC靶通路存在显著改变,这些通路可能成为预防放疗耐药的潜在靶点。
研究设计与样本
- 回顾性分析前瞻性维护数据库,采用线性微阵列分析和监督基因集富集分析比较未放疗与放疗后复发头颈癌样本。
- 共分析157例患者,其中96例(61%)未放疗,61例(39%)接受过放疗。
主要发现
- 放疗后血管生成、蛋白翻译机器、细胞周期调控和生长因子相关基因上调,Myc活性和缺氧反应相关基因下调(所有P < .001)。
- 放疗后头颈癌Wnt/β-catenin通路42个基因中19个下调(P = .045)。
- 放疗后头颈癌MYC靶通路199个基因中119个下调(P = .024)。
关键数值与推荐
- 放疗后复发头颈癌Wnt/β-catenin通路42个基因中19个下调,P = .045。
- 放疗后复发头颈癌MYC靶通路199个基因中119个下调,P = .024。
- 放疗后血管生成、蛋白翻译机器、细胞周期调控和生长因子相关基因上调,Myc活性和缺氧反应相关基因下调,均P < .001。
临床怎么用
- 对于放疗后复发的头颈癌,可关注Wnt/β-catenin和MYC靶通路作为潜在干预靶点以预防放疗耐药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiotherapy (RT) is an integral component in the treatment of head and neck cancer (HNC).We hypothesized there would be alterations in gene-expression and pathway activity in HNC samples obtained in recurrent HNC that were previously treated with RT, when compared to RT-naïve disease. METHODS: Patient data was abstracted from a prospectively maintained database. Linear-microarray analysis and supervised gene-set enrichment-analysis were employed to compare RT-naive and recurrent disease after prior-RT. RESULTS: A total of 157 patients were analyzed, 96 (61%) were RT-naive and 61 (39%) had RT.After radiation, there was upregulation of genes associated with angiogenesis, protein-translation-machinery, cell-cycle regulation, and growth factors, and downregulation associated with Myc activity, and hypoxic response (all P < .001).Previously irradiated HNC was associated with downregulation in 19/42 genes in the Wnt/B-catenin-pathway (P = .045)and 119/199 genes involved in the MYC target pathway (P = .024). CONCLUSION: Patients with recurrences salvaged surgically post-RT had significant alterations in gene-expression and in Wnt/B-catenin and MYC-target pathways. These pathways may represent potential targets to prevent development of resistance to RT.
引用
- Naghavi AO, Kim Y, Yang GQ, et al. Alterations in genetic pathways following radiotherapy for head and neck cancer. Head Neck. 2019. PMID: 31833149. doi:10.1002/hed.26004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。